Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on January 19, 2004

Circulation. 2004
Published online before print January 19, 2004, doi: 10.1161/01.CIR.0000109699.45186.30
A more recent version of this article appeared on February 3, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
109/4/537    most recent
01.CIR.0000109699.45186.30v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, S.
Right arrow Articles by Sudhir, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, S.
Right arrow Articles by Sudhir, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
Related Collections
Right arrow Risk Factors

Submitted on July 9, 2003
Revised on September 26, 2003
Accepted on September 26, 2003

Endogenous Estrogen Deficiency Reduces Proliferation and Enhances Apoptosis-Related Death in Vascular Smooth Muscle Cells. Insights From the Aromatase-Knockout Mouse

Shanhong Ling MD, Aozhi Dai MD, Rodney J. Dilley PhD, Margaret Jones PhD, Evan Simpson PhD, Paul A. Komesaroff MD, PhD, and Krishnankutty Sudhir MD, PhD*

From Baker Medical Research Institute, Melbourne (S.L., A.D., R.J.D., P.A.K., K.S.), and Prince Henry’s Institute for Medical Research, Clayton (M.J., E.S.), Victoria, Australia.

* To whom correspondence should be addressed. E-mail: ksudhir{at}cvmed.stanford.edu.

Background--Altered proliferation and death of vascular smooth muscle cells (VSMCs) are important mechanisms in vascular growth and remodeling. This study examined the effect of endogenous estrogens on VSMC proliferation.

Methods and Results--An estrogen-deficient animal model, the aromatase-knockout (ArKO) mouse, was used. Primary cultures of VSMCs were established from aortas of 11-week-old male and female ArKO and wild-type (WT) mice. In ArKO cells, the absence of aromatase cytochrome P450 mRNA expression was demonstrated by reverse transcription-polymerase chain reaction; Western blotting showed normal expression of estrogen receptor protein. Proliferative responses to serum or platelet-derived growth factor-BB were lower in ArKO than WT cells; 17{beta}-estradiol (E2, 10 nmol/L) enhanced the response to platelet-derived growth factor-BB in ArKO cells but inhibited the response in WT cells. E2 inhibited activity of mitogen-activated protein kinase ERK1/2 in WT but not ArKO cells. Apoptosis-related death caused by tumor necrosis factor-{alpha} was greater in ArKO than in WT cells; this effect in ArKO was attenuated by E2. Differences in VSMC proliferation between ArKO and WT occurred in both sexes. Morphological studies in aortas derived from male mice at 1 year of age demonstrated that medial smooth muscle area was {approx}10% less in ArKO than WT mice at this age.

Conclusions--Deficiency of endogenous estrogens reduces proliferation and enhances apoptosis-related death in VSMCs; exogenous E2 corrects these abnormalities.


Key words: apoptosis • hormones • muscle, smooth • proliferation




This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
H. Okura, Y. Takada, A. Yamabe, T. Kubo, K. Asawa, T. Ozaki, H. Yamagishi, I. Toda, M. Yoshiyama, J. Yoshikawa, et al.
Age- and Gender-Specific Changes in the Left Ventricular Relaxation: A Doppler Echocardiographic Study in Healthy Individuals
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 41 - 46.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. D. Krom, N. M.M. Pires, J. W. Jukema, M. R. de Vries, R. R. Frants, L. M. Havekes, K. W. van Dijk, and P. H.A. Quax
Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists
Cardiovasc Res, January 1, 2007; 73(1): 217 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. J. Handelsman
The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1646 - 1653.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
O. W.H. van der Heijden, Y. P.G. Essers, M. E.A. Spaanderman, J. G.R. De Mey, G. J.J.M. van Eys, and L. L.H. Peeters
Uterine Artery Remodeling in Pseudopregnancy Is Comparable to That in Early Pregnancy
Biol Reprod, December 1, 2005; 73(6): 1289 - 1293.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.M. O. Farouque, J. A. Tremmel, F. R. Shabari, M. Aggarwal, W. F. Fearon, M. K.C. Ng, M. Rezaee, A. C. Yeung, and D. P. Lee
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices
J. Am. Coll. Cardiol., February 1, 2005; 45(3): 363 - 368.
[Abstract] [Full Text] [PDF]